SCHEMBL931787

SCHEMBL931787

NC(CCC(=O)O)C(=O)NC(CS)C(=O)NCC(=O)O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.70
GSTK1 Q9Y2Q3 1/20 0.70
DPP4 P27487 1/20 0.48
DPP8 Q6V1X1 1/20 0.48
DPP9 Q86TI2 1/20 0.48
GLO1 Q04760 1/20 0.45
FOLH1 Q04609 1/20 0.44
ENPEP Q07075 7/20 0.43
ANPEP P15144 4/20 0.43
GRM8 O00222 1/20 0.42
GRM6 O15303 1/20 0.42
GRIN2D O15399 1/20 0.42
GRIN3B O60391 1/20 0.42
GSR P00390 1/20 0.42
CYP1A2 P05177 1/20 0.42
GRIK1 P39086 1/20 0.42
GRM5 P41594 1/20 0.42
GRIA1 P42261 1/20 0.42
GRIA2 P42262 1/20 0.42
GRIA3 P42263 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL209654 1.00 PTGS1 (0.70) PTGS1GSTK1DPP4DPP8DPP9
Sulfurous Acid SCHEMBL15348261 0.94 PTGS1 (0.64) PTGS1GSTK1DPP4DPP8DPP9
SCHEMBL15333593 0.91 PTGS1 (0.67) PTGS1GSTK1DPP4DPP8DPP9
SCHEMBL209655 0.91 PTGS1 (0.67) PTGS1GSTK1DPP4DPP8DPP9
Glutathione SCHEMBL711491 0.91 PTGS1 (0.88) PTGS1GSTK1DPP4DPP8DPP9
SCHEMBL15348170 0.90 PTGS1 (0.65) PTGS1GSTK1DPP4DPP8DPP9
SCHEMBL173099 0.89 PTGS1 (0.55) PTGS1GSTK1DPP4DPP8DPP9
SCHEMBL29384215 0.89 PTGS1 (0.55) PTGS1GSTK1DPP4DPP8DPP9
SCHEMBL15348168 0.89 PTGS1 (0.56) PTGS1GSTK1DPP4DPP8DPP9
SCHEMBL22589611 0.89 PTGS1 (0.60) PTGS1GSTK1DPP4DPP8DPP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230279342-A1 METHOD FOR MEDIUM TREATMENT BEFORE INOCULATION HOFFMANN-LA ROCHE INC. (US) 2023-09-07 US claimed
EP-4136212-A1 METHOD FOR MEDIUM TREATMENT BEFORE INOCULATION Genentech, Inc. (US) 2023-02-22 EP claimed
WO-2021209512-A1 METHOD FOR MEDIUM TREATMENT BEFORE INOCULATION GENENTECH, INC. (US) 2021-10-21 WO claimed
EP-2398500-A2 GLUTATHIONE-BASED DRUG DELIVERY SYSTEM TO-BBB Holding B.V. (NL) 2011-12-28 EP claimed
WO-2010095940-A2 GLUTATHIONE-BASED DRUG DELIVERY SYSTEM TO-BBB HOLDING B.V. (NL) 2010-08-26 WO claimed
EP-2032145-A2 STRUCTURAL-BASED INHIBITORS OF THE GLUTATHIONE BINDING SITE IN ALDOSE REDUCTASE, METHODS OF SCREENING THEREFOR AND METHODS OF USE The Board of Regents of The University of Texas System (US) 2009-03-11 EP claimed
WO-2008002678-A2 STRUCTURAL-BASED INHIBITORS OF THE GLUTATHIONE BINDING SITE IN ALDOSE REDUCTASE, METHODS OF SCREENING THEREFOR AND METHODS OF USE THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2008-01-03 WO claimed
JP-10273438-A None JP disclosed
CN-119838016-A A pharmaceutical composition with broad-spectrum anti-infectious and broad-spectrum anticancer effects 单立华 2025-04-18 CN disclosed
WO-2025006992-A2 COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-01-02 WO disclosed
WO-2024105221-A1 COMBINATION FOR USE IN BRAIN HEALTH AND INCREASING MENTAL PERFORMANCE Société des Produits Nestlé S.A. (CH) 2024-05-23 WO disclosed
EP-4370144-A1 GLUTAHTIONE C4 AGAINST AIRWAY AFFECTIONS Redox-co S.r.l. (IT) 2024-05-22 EP disclosed
CN-114045296-B Protein and related products and uses thereof 上海交通大学 2024-05-14 CN disclosed
US-6280925-B1 INCUBATING TISSUE IN FREEZE RESISTANT SOLUTION; MIX TISSUE WITH ANTIOXIDANT AND FREEZE RESISTANT SOLUTION, RECOVER TISSUE AND EVALUATE FOR HYPERPLASIA ORGAN RECOVERY SYSTEMS, INC. 2001-08-28 US disclosed
EP-1015603-A2 NEW PLANT GENES RHONE-POULENC AGRICULTURE LTD. (GB) 2000-07-05 EP disclosed
WO-1999014337-A2 NEW PLANT GENES RHONE-POULENC AGRICULTURE LIMITED (GB) 1999-03-25 WO disclosed
JP-H10273438-A TREATMENT COMPOSITION FOR CHRONIC TRAUMA JOHNSON & JOHNSON MEDICAL LTD 1998-10-13 JP disclosed
WO-1995026719-A1 METHOD FOR DELIVERING BIOLOGICALLY ACTIVE MATERIALS USING A THIOESTER OR THIOETHER PRODRUG ARCTURUS PHARMACEUTICAL CORPORATION (US) 1995-10-12 WO disclosed
US-4837361-A COMBINATION REDUCING AGENTS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) 1989-06-06 US disclosed
US-4732744-A TREATMENT WITH IRON CHELATE OF AMINO ACID CONTAINING MERCAPTAN THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) 1988-03-22 US disclosed